Summit Global Investments’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.49M Buy
14,684
+81
+0.6% +$16.8K 0.19% 64
2026
Q1
$3.09M Sell
14,603
-10,602
-42% -$2.28M 0.18% 62
2025
Q4
$5.18M Sell
25,205
-36,509
-59% -$6.87M 0.31% 40
2025
Q3
$9.69M Buy
61,714
+13,191
+27% +$2.04M 0.57% 28
2025
Q2
$8.15M Sell
48,523
-11,218
-19% -$1.66M 0.48% 32
2025
Q1
$8.23M Sell
59,741
-22,367
-27% -$2.85M 0.6% 29
2024
Q4
$9.71M Sell
82,108
-21,492
-21% -$2.51M 0.61% 36
2024
Q3
$11.4M Sell
103,600
-15,188
-13% -$1.59M 0.73% 31
2024
Q2
$11.7M Buy
118,788
+3,244
+3% +$331K 0.79% 26
2024
Q1
$12.9M Buy
115,544
+105,714
+1,075% +$11.4M 0.96% 24
2023
Q4
$991K Buy
+9,830
New +$975K 0.06% 241
2018
Q2
Sell
-7,830
Closed -$491K 260
2018
Q1
$491K Buy
+7,830
New +$537K 0.08% 244

Other funds holding CAH

Summit Global Investments's CAH Position: Q2 2026 in Review

Summit Global Investments increased its Cardinal Health (CAH) stake by 0.55% in Q2 2026, buying an estimated $16.8K and bringing the position to 14,684 shares worth $3.49M. The position accounts for 0.19% of the portfolio, ranked #64.

Summit Global Investments first reported a position in CAH in Q1 2018 and has held it in 12 quarters since. The position peaked at $12.9M in Q1 2024. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Summit Global Investments held 14,684 shares of Cardinal Health worth $3.49M as of Q2 2026.
  • Summit Global Investments bought 81 Cardinal Health shares in Q2 2026, an estimated $16.8K.
  • Cardinal Health made up 0.19% of Summit Global Investments's portfolio in Q2 2026, its #64 holding.
  • Summit Global Investments first reported a position in Cardinal Health in Q1 2018 and has held it in 12 quarters since.
  • Summit Global Investments's Cardinal Health position peaked at $12.9M in Q1 2024.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.